EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Exploring the Role of Macrophage Marker CD68 in Pediatric Acute Myeloid Leukemia

Laurens Van Camp iD, Jolien Vanhooren iD, Barbara Depreter iD, Mattias Hofmans iD, Inge D'Hont iD, Christophe Chantrain iD, Laurence Dedeken iD, An Van Damme iD, Anne Uyttebroeck iD, Tim Lammens iD, Barbara De Moerloose iD

International Journal of Molecular Sciences · 05.06.2026 · 27 (11) · 5136

DOI: 10.3390/ijms27115136 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 05.06.2026. Verfasst von Laurens Van Camp und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Hematology-Oncology and Stem Cell Transplantation, Ghent University Hospital, 9000 Ghent, Belgium. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute, Antigens, Differentiation, Myelomonocytic, Antigens, CD, Macrophages. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kinderkankerfonds vzw, Olivia Hendrickx Research Fund vzw, Kom Op Tegen Kanker.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pediatric acute myeloid leukemia (pedAML) is a childhood malignancy with relapse rates of approximately 30%. CD68, a macrophage marker involved in phagocytosis and macrophage recruitment, may contribute to AML biology. We analyzed CD68 expression using the TARGET database and performed survival analyses, mRNA/protein profiling, and functional assays in AML cell lines, pedAML samples, and cord blood samples. High CD68 transcript levels correlated with KMT2A-rearrangements and inversion 16. Survival analysis showed that high CD68 predicted worse event-free survival, though not independently in a multivariate analysis. Flow cytometry confirmed higher CD68 expression in 7/8 pedAML samples compared to cord blood samples. Functionally, CD68 knockdown reduced proliferation and increased drug sensitivity, while overexpression promoted growth and resistance. Gene set enrichment analysis (GSEA) indicated enrichment of MAPK signaling, AP-1–mediated stress response, and epithelial–mesenchymal transition (EMT)/migration-associated pathways in CD68-high models. Together, these findings suggest that CD68 contributes to a pro-tumorigenic and stress-adaptive phenotype in pedAML and may represent a biologically relevant therapeutic target.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia, Myeloid, AcuteAntigens, Differentiation, MyelomonocyticAntigens, CDMacrophagesBiomarkers, TumorHumansCD68 MoleculeChildCell Line, TumorFemaleMaleCell ProliferationEpithelial-Mesenchymal TransitionChild, Preschool

Stichwörter der Autor:innen

AMLCD68biologymacrophage markerpediatric acute myeloid leukemiatargeted therapy

Substanzen

Antigens, Differentiation, MyelomonocyticAntigens, CDCD68 MoleculeCD68 antigen, humanBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Pediatric Hematology-Oncology and Stem Cell Transplantation, Ghent University Hospital, 9000 Ghent, Belgium.
  • Department of Internal Medicine and Pediatrics, Ghent University, 9000 Ghent, Belgium.
  • Cancer Research Institute Ghent (CRIG), 9000 Ghent, Belgium.
  • Department of Laboratory Medicine, AZ Delta General Hospital, 8800 Roeselare, Belgium.
  • Department Pharmaceutical Sciences (FARM), University Hospital Brussels, 1090 Brussels, Belgium.
  • Department of Diagnostic Sciences, Ghent University, 9000 Ghent, Belgium.

ORCID-Profile: Laurens Van Camp, Jolien Vanhooren, Barbara Depreter, Mattias Hofmans, Inge D'Hont, Christophe Chantrain, Laurence Dedeken, An Van Damme, Anne Uyttebroeck, Tim Lammens, Barbara De Moerloose

Förderung

  • Kinderkankerfonds vzw
  • Olivia Hendrickx Research Fund vzw
  • Kom Op Tegen Kanker

Zitieren

APA

Van Camp, L., Vanhooren, J., Depreter, B., Hofmans, M., D'Hont, I., Chantrain, C., Dedeken, L., Van Damme, A., Uyttebroeck, A., Lammens, T., & De Moerloose, B. (2026). Exploring the Role of Macrophage Marker CD68 in Pediatric Acute Myeloid Leukemia. International Journal of Molecular Sciences, 27(11), 5136. https://doi.org/10.3390/ijms27115136

Vancouver

Van Camp L, Vanhooren J, Depreter B, Hofmans M, D'Hont I, Chantrain C, et al. Exploring the Role of Macrophage Marker CD68 in Pediatric Acute Myeloid Leukemia. International Journal of Molecular Sciences. 2026;27(11):5136. doi:10.3390/ijms27115136

BibTeX
@article{VanCamp2026,
  author = {Van Camp, Laurens and Vanhooren, Jolien and Depreter, Barbara and Hofmans, Mattias and D'Hont, Inge and Chantrain, Christophe and Dedeken, Laurence and Van Damme, An and Uyttebroeck, Anne and Lammens, Tim and De Moerloose, Barbara},
  title = {Exploring the Role of Macrophage Marker CD68 in Pediatric Acute Myeloid Leukemia},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {11},
  pages = {5136},
  doi = {10.3390/ijms27115136}
}
Kostenlos starten →